Binding of PD-L1 to PD-1 on naive tumor-infiltrating lymphocytes (TILs) can arrest the process of antigen presenting at the effector phase and suppress T-cell activation, migration, proliferation and secretion of cytotoxic mediators. Here, PDCD1 is linked to neoplasm.